Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment Leonidas ApostolidisKristin LangGeorg Martin Haag Original Article – Clinical Oncology Open access 19 April 2022 Pages: 1373 - 1382
Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma Jinsong BaiChaoqiang DengHaiquan Chen Original Article – Clinical Oncology 20 April 2022 Pages: 1383 - 1389
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study Valerie Catherine LinzCarina SchwanbeckMarco Johannes Battista Original Article – Clinical Oncology Open access 22 April 2022 Pages: 1391 - 1399
Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma Astrid BauschkeAnnelore Altendorf-HofmannUtz Settmacher Original Article – Clinical Oncology Open access 22 April 2022 Pages: 1401 - 1410
Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study Sven H. LoosenKarel KostevChristoph Roderburg Original Article – Clinical Oncology Open access 27 April 2022 Pages: 1411 - 1416
Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastasis: results from the ALTER 0303 phase 3 randomized clinical trial Yinchen ShenJun LuBaohui Han Original Article – Clinical Oncology 28 April 2022 Pages: 1417 - 1424
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades Cheng-Long HanYu-Chuan YanTao Li Original Article – Clinical Oncology 28 April 2022 Pages: 1425 - 1441
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China Xiao HanJun GuoZhehai Wang Original Article – Clinical Oncology 28 April 2022 Pages: 1443 - 1451
Serum lactate dehydrogenase as a novel prognostic factor for patients with primary undifferentiated pleomorphic sarcomas Qiaowei LinZhengwang SunWangjun Yan Original Article – Clinical Oncology 29 April 2022 Pages: 1453 - 1463
Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization Thilo GambichlerKai HornyJürgen C. Becker Original Article – Clinical Oncology Open access 03 May 2022 Pages: 1465 - 1471
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC) Audrey GrainFanny Rialland-BattistiAndré Baruchel Original Article – Clinical Oncology 04 May 2022 Pages: 1473 - 1483
Two-cavities approach for resection of pediatric abdominal neuroblastic tumors: experience of a national reference pediatric onco-surgical center Cristian UrlaSteven W. WarmannJörg Fuchs Original Article – Clinical Oncology Open access 06 May 2022 Pages: 1485 - 1493
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach Fabienne EnglmeierAnnalen BleckmannKlaus Nagels Original Article – Clinical Oncology Open access 09 May 2022 Pages: 1495 - 1511
Non-iatrogenic implantation of cutaneous metastasis from hepatocellular carcinoma Junjun JiaJia LuoJun Yu Original Article – Clinical Oncology 10 May 2022 Pages: 1513 - 1519
Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 85 years: EGC-2 model Yosuke ToyaTomohiro ShimadaTohoku GI Endoscopy Group Original Article – Clinical Oncology 11 May 2022 Pages: 1521 - 1530
Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors’ therapeutic outcomes for non-small cell lung cancer Jiajia SongLing BaiBinwu Ying Original Article – Clinical Oncology 17 May 2022 Pages: 1531 - 1540
All EGFR mutations are (not) created equal: focus on uncommon EGFR mutations Batra UllasNathany ShrinidhiMehta Anurag Original Article – Clinical Oncology 17 May 2022 Pages: 1541 - 1549
Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study Katharina AnicFriedrich FlohrMarco Johannes Battista Original Article – Clinical Oncology Open access 17 May 2022 Pages: 1551 - 1560
Top 10 research priorities in colorectal cancer: results from the Colorectal Cancer Priority-Setting Partnership Rosa KlotzMagdalena HolzeSteering Group Forschungspartnerschaft Darmkrebs/Priority Setting Colorectal Cancer Original Article – Clinical Oncology Open access 17 May 2022 Pages: 1561 - 1568
Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia Romy ToberUlf SchnetzkeSebastian Scholl Original Article – Clinical Oncology Open access 18 May 2022 Pages: 1569 - 1583
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities Mitra ZabihiRamin LotfiDavood Bashash Review 04 July 2022 Pages: 1585 - 1606
Pleiotropic effects of cell competition between normal and transformed cells in mammalian cancers Jing YuYamin ZhangHuiyong Zhu Review 07 July 2022 Pages: 1607 - 1619
RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy Subhadra KumariSantosh KumarSrinivasan Muthuswamy Review 07 July 2022 Pages: 1621 - 1633
Current status of the association between malnutrition defined by the GLIM criteria and postoperative outcomes in gastrointestinal surgery for cancer: a narrative review Ryota MatsuiKazuma RifuTetsu Fukunaga Review 08 July 2022 Pages: 1635 - 1643
Recent advances in sonodynamic immunotherapy Jia-Rui DuYang WangZhi-Xia Sun Review 13 July 2022 Pages: 1645 - 1656
SDC4-rs1981429, ATM-rs228590 and biomarkers of breast cancer risk Rujittika MungmunpuntipantipViroj Wiwanitkit Correspondence 06 November 2022 Pages: 1657 - 1657
Association between skin immune-related adverse events (irAEs) and multisystem irAEs during PD-1/PD-L1 inhibitor monotherapy Atsushi YamaguchiYoshitaka SaitoMasaki Kobayashi Correspondence 08 November 2022 Pages: 1659 - 1666
